Wordt geladen...
HOW BEST TO USE NEW THERAPIES IN MULTIPLE MYELOMA
Advances in the molecular understanding of myeloma have led to the development of novel agents such as immunomodulatory drugs (IMiDs) and proteasome inhibitors (bortezomib). When used alone, these agents have significant activity against myeloma and responses increase significantly when they are com...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2867034/ https://ncbi.nlm.nih.gov/pubmed/20359801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2010.03.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|